Back to top

View the PFP Archive

Stocks closed sharply higher again yesterday, led by the mid-cap S&P 400 and small-cap Russell 2000 with 1.44% and 1.37% respectively.
Kevin Matras   
Profit from the Pros
By Kevin Matras
Executive Vice President
Zacks Investment Research
  

Stocks Up Again Yesterday, Off To A Great Start For 2026

Stocks closed sharply higher again yesterday, led by the mid-cap S&P 400 and small-cap Russell 2000 with 1.44% and 1.37% respectively. The big 3 indexes were no slouches either with the Dow up 0.99%, the S&P 500 up 0.62%, and the Nasdaq up 0.65%.

Yesterday's Motor Vehicle Sales report showed total vehicle sales for December at 16.0 million units (annually) vs. last month's upwardly revised 15.7M (from 15.6M), and views for the same. North American-Made Sales came in at 12.7M vs. last month's upwardly revised 12.3M (from 12.1M).

In other news, it was reported on Monday that NVIDIA has plans to get into the robotaxi business as early as 2027. They appear interested in partnering with someone, at first, in a limited way. But it underscores their ambition to use their technology in the autonomous vehicle segment.

Speaking of NVIDIA, they reported seeing "very high" Chinese demand for their H200 AI chips. It was only last month that the Trump Administration allowed NVIDIA to sell these chips to China, which were previously restricted. The caveat is that the U.S. government gets 25% of the revenue. But that's still a hefty portion left for the company.

And speaking of AI chips, AMD CEO Lisa Su said that "AI is for everyone" and that "AI is the most important technology of the last 50 years." She noted that "demand for AI is just incredible," and "it's going through the roof."

Her comments are just the latest to underscore that the AI boom is alive and well.

Separately, but also AI related, Elon Musk announced that he's raised $20 billion for his xAI. And it includes plenty of investment firms, as well as some big names in the AI space like NVIDIA and Cisco, to name a couple.

Switching gears, word has it that the Supreme Court has marked this Friday as an 'opinion day,' which is when they will begin releasing written decisions in argued cases. They have not said, one way or the other, whether they will have a decision on President Trump's tariffs. But Friday would be the soonest it could come. We shall see.

That could have a big impact on the market. Will a favorable ruling for the Administration be cheered, as it will allow the President to continue to pursue his economic agenda, without detour? Or could a negative ruling against the White House weigh on the market, as it will inject new uncertainty into the economy and the market? Or something else? Again, no guarantee we'll get a ruling on Friday, but it's the first day it could potentially come.

Today we'll get MBA Mortgage Applications, Factory Orders, the ISM Services Index, and the ADP Employment Report.

But today's jobs numbers, and tomorrow's (Weekly Jobless Claims and the Challenger Job-Cut report) are just appetizers. The main course is Friday's always important Employment Situation report.

With the Fed believing there's more downside risk to the labor market, given easing inflation numbers, all eyes will be on Friday's report.

And whatever it shows, it could have an impact on what the Fed does with interest rates at their next meeting on January 27-28.

But first things first, and that's today.

Three trading days into the new year, and stocks are off to a great start. Already, the Dow is up 2.91%, the S&P is up 1.45%, the Nasdaq is up 1.31%, the small-cap Russell 2000 is up 4.07%, and the mid-cap S&P 400 is up 4.18%.

Wow.

See you tomorrow,

Kevin Matras

Executive Vice President, Zacks Investment Research

Sponsor

Hurry Before the Bell Rings

Med-X is gearing up for a Nasdaq listing (MXRX)–but the real opportunity is now, before Wall Street takes notice. Their all-natural Nature-Cide pesticides are already on shelves at e-commerce giants like Walmart, Amazon, and Kroger, with $6.4M in revenue and expansion into 41+ markets.

As climate, regulation, and consumer demand drive a $17B industry toward natural solutions, Med-X is positioned to lead. Shares are just $4.00 through a limited Reg A+ offering.

Don't wait for the headlines–[Review the Med-X investment opportunity today]


Disclosures: This is a paid advertisement for Med-X's Regulation A+ Offering. Please read the offering circular at invest.medx-rx.com

Most Popular Articles from Zacks.com

Image: Bigstock

Why SMRs will Play a Key Role in the AI Supercycle

The convergence of AI's immense processing needs and the Administration's aggressive push for nuclear energy has created a unique "perfect storm" for Small Modular Reactors. Read More »

Why Defense Stocks & ETFs Can Continue to Soar

Rising geopolitical risks are fueling a rally in defense and aerospace ETFS like ITA, XAR and EUAD. Read More »

Image: Bigstock

Buy Nvidia or AMD Stock After Rolling Out New AI Platforms?

Presentations of their next-gen AI platforms at the 2026 CES could lift the appealing outlook for AMD and NVDA. Read More »

Image: Bigstock

QBTS, RGTI Beat NVDA in 2025: Can Quantum Win Again in 2026?

Investor optimism toward quantum computing is reaching a new high, fueled by tangible technological progress and solid stock performance last year by QBTS and RGTI. Read More »

Image: Bigstock

S&P 500 Clocks 3 Straight Years of Stellar Run: 3 Tech Funds to Buy

The three-year surge of the S&P 500, powered by tech and AI, puts the spotlight on FSELX, PRSCX and JNGTX as funds to watch. Read More »

Sponsor

Just Released: 4 Stocks for Biggest Upside in Q1

Four Zacks experts each announce their single favorite stock to gain the most in the next three months:

Stock #1: Chip Maker Tapping a New Multibillion-Dollar Market

Stock #2: Investment Firm Trading Cheap Despite Record Growth

Stock #3: Mobility Platform Now Generating Major Cash Flow

Stock #4: Construction Company Building America's Power Grid

Today, you are invited to download the private Ultimate Four Special Report that names these stocks and spotlights why their gain potential is so immediate and exceptional.

See Stocks Now »

Image: Bigstock

Bull of the Day: Robinhood Markets (HOOD)

Robinhood's latest quarterly results broke records across several key metrics, also crushing our consensus EPS and sales estimates. Read More »

New Zacks Strong Buys for January 7th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today. Read More »

 

Download our app for convenient on-the-go access to even more—daily and weekly newsletters published by Zacks experts, proprietary research and tools, and Portfolio Tracker on Zacks.com.

Download our Zacks App for Apple iOS
Download our Zacks App for Android

Visit Success Stories to hear how Zacks research, tools and portfolios help our members outperform the market.